Certified by Founder Lodge 
                                        
                                        Reverb Therapeutics
 
                                                 Canada  -  Vancouver, British columbia 
                                             START UP 
                                                                                    1 Disclosed Funding Rounds $21,000,000
                                            0 Participating Investments
- 
                                                Founded date 
                                                
2023
 - 
                                                Operating Status 
                                                
Active
 - 
                                                Last Funding Type 
                                                
Seed
 - 
                                                Company Type 
                                                
For Profit
 - Website
 - Contact
 - Social Links
 
                                            We develop bispecific antibodies that exploit the potential of the natural immune system. Our Amplify•R platform amplifies and redirects endogenous cytokine signaling instead of recombinant 
                                        
                                        
                                        
                                                                                
                                        
                                                                                | Date | Round | Raised | Participating Investors | 
|---|---|---|---|
| February, 21 ,2025 | Seed | $21,000,000 | 
                                                
 KdT Ventures
                                                                                
                                                                            
 Amplitude Ventures
                                                                                
 InBC Investment Corp.
                                                                                
 Seido Capital
                                                                                
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
 
                                            
                                                                        
                                IORGANBIO |  $2,000,000  | (Oct 30, 2025)
                                                                        
                                Sparrow BioAcoustics |  $10,000,000  | (Oct 30, 2025)
                                                                        
                                Vesence |  $9,000,000  | (Oct 30, 2025)
                                                                        
                                Homecourt |  $8,000,000  | (Oct 30, 2025)
                                                                        
                                Reflectiz |  $22,000,000  | (Oct 30, 2025)